Your basket is currently empty!
MHC Class I Pentamer Publication
Pro5® MHC Class I Pentamers Publications
Pentamer Research Areas – Select a disease area to view publications demonstrating the use of Pentamers
| AAV | Adenovirus | Autoimmunity | BK Virus |
| Cancer | Chlamydia | CMV | COVID-19 / SARS-CoV-2 |
| Dengue | EBV | HAV | HBV |
| HCV | HIV/SIV | HPV | HSV |
| HTLV | Influenza | JC Virus | LCMV |
| Listeria | Malaria | MiHAg | Model Antigens |
| MuLV | Negative | Norovirus | Other |
| Rabies | RSV | Sendai Virus | SV40 Virus |
| Toxoplasma gondii | Trypanosoma | Tuberculosis | Vaccinia |
| Varicella Zoster Virus | VSV | West Nile Virus | Yellow Fever Virus |
| Publication/Disease Area | Specificity |
|---|---|
Adeno-associated Virus (AAV) | |
| Hui DJ, et al. (2015). “AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes.” Mol Ther Methods Clin Dev. https://doi.org/10.1038/mtm.2015.29 | A*01:01/SADNNNSEY |
| Hui DJ, et al. (2015). “AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes.” Mol Ther Methods Clin Dev. https://doi.org/10.1038/mtm.2015.29 | B*07:02/VPQYGYLTL |
| Finn J, et al. (2010). “Proteasome Inhibitors Decrease AAV2 Capsid derived Peptide Epitope Presentation on MHC Class I Following Transduction.“Molecular Therapy, 18, 135-142. https://doi.org/10.1038/mt.2009.257 | B*07:02/VPQYGYLTL |
Adenovirus | |
| Tischer S, et al. (2016) “Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection.” J Transl Med. https://doi.org/10.1186/s12967-016-1042-2 | A*01:01/TDLGQNLLY |
| Leen AM, et al. (2008). “Identification of Hexon-Specific CD4 and CD8 T-Cell Epitopes for Vaccine and Immunotherapy.” J Virol82:. https://doi.org/10.1128/jvi.01689-07 | A*01:01/TDLGQNLLY |
| Sun J, et al. (2015). “Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application.” J Immunother Cancer. https://doi.org/10.1186/s40425-015-0049-1 | A*24:02/TYFSLNNKF |
| Leen AM, et al. (2008). “Identification of Hexon-Specific CD4 and CD8 T-Cell Epitopes for Vaccine and Immunotherapy.” J Virol82:. https://doi.org/10.1128/jvi.01689-07 | B*07:02/KPYSGTAYNAL |
| Leen AM, et al. (2008). “Identification of Hexon-Specific CD4 and CD8 T-Cell Epitopes for Vaccine and Immunotherapy.” J Virol82:. https://doi.org/10.1128/jvi.01689-07 | B*35:01/IPYLDGTFY |
Autoimmunity | |
| Perri V, et al. (2017). “Identification of GAD65 AA 114-122 reactive ‘memory-like’ NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers.” PLoS ONE 12(12): e0189615. https://doi.org/10.1371/journal.pone.0189615 | A*02:01/VMNILLQYV |
| Ankathatti Munegowda M, et al. (2011) “A distinct role of CD4+ Th17- and Th17-stimulated CD8+ CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis.” J Clin Immunol. https://doi.org/10.1007/s10875-011-9549-z | H-2Db/RSPFSRVVHL |
Cancer | |
| Ma YT, et al. (2025). “Addition of Dendritic Cell Vaccination to Conditioning Cyclophosphamide and Chemoembolization in Patients with Hepatocellular Carcinoma: The ImmunoTACE Trial.” Clin Cancer Res. https://doi.org/10.1158/1078-0432.ccr-25-0142 | A*02:01/FMNKFIYEI |
| Kang S, et al. (2024). “Engineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunotherapy.” Journal for ImmunoTherapy of Cancer 2024;12:e009541. https:// doi. org/ 10. 1136/jitc- 2024- 009541 | A*02:01/FVWLHYYSV |
| R. Wang, et al. (2026) “Tumor-Derived CDC37 Inhibits Antigen Cross-Presentation in Dendritic Cells and Impairs Anti-Tumor Immunity in Breast Cancer.” Adv. Sci.13, no. 5 (2026): e06518. https://doi.org/10.1002/advs.202506518 | A*02:01/LLLLTVLTV |
| Schuler, P.J.,et al. (2026). “Immune checkpoint inhibition increases antigen-specific T cell response in head and neck cancer.” Sci Rep 16, 5583. https://doi.org/10.1038/s41598-026-38740-z | A*02:01/SLLMWITQC |
| Zhou, C., et al. (2024) “Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death.” Nat Commun 15, 499. https://doi.org/10.1038/s41467-024-44779-1 | A*02:01/YLSGANLNL |
| Seretis, A. et al. (2025) “Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma.” Vaccines 2025, 13, 346. https://doi.org/10.3390/vaccines13040346 | H-2Kb/SVYDFFVWL |
| Pearson, J.R.D., et al. (2024). “TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors.” Cancer Immunol Immunother 73, 178. https://doi.org/10.1007/s00262-024-03770-x | H-2Kb/SVYDFFVWL |
| Ostroumov, D., et al. (2025) “Sequential STING and CD40 agonism drives massive expansion of tumor-specific T cells in liposomal peptide vaccines.” Cell Mol Immunol 22, 150–160. https://doi.org/10.1038/s41423-024-01249-4 | H-2Db/ASMTNMELM |
| Rongsheng Z., et al. (2026). “Chimeric MHC class I– and II–restricted non-self epitopes broaden antitumor T cell reactions.” J Exp Med; 223 (2): e20250025. https://doi.org/10.1084/jem.20250025 | H-2Db/ASMTNMELM |
| Zhang, W., et al. (2024) “NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy.” Cancer Immunol Immunother 73, 245. https://doi.org/10.1007/s00262-024-03830-2 | H-2Db/ASMTNMELM |
| Seretis, A. et al. (2025) “Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma.” Vaccines 2025, 13, 346. https://doi.org/10.3390/vaccines13040346 | H-2Db/KVPRNQDWL |
Cytomegalovirus (CMV) | |
| Fan J., et al. (2024). “IL-15-induced CD38+HLA-DR+CD8+ T cells correlate with liver injury via NKG2D in chronic hepatitis B cirrhosis.” Clin Transl Immunology. 13(10):e70007. doi: 10.1002/cti2.70007. https://doi.org/10.1002/cti2.70007 | A*02:01/NLVPMVATV |
| Peña-Asensio J, et al. (2023). “IL-15 boosts activated HBV core-specific CD8+ progenitor cells via metabolic rebalancing in persistent HBV infection.“iScience, 2023; 27. https://doi.org/10.1016/j.isci.2023.108666 | A*02:01/NLVPMVATV |
| Troise F, et al. (2024) “Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors.” Molecular Therapy Oncology, 2024; 32. https://doi.org/10.1016/j.omton.2024.200760 | H-2Db/HGIRNASFI |
| Troise F, et al. (2024) “Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors.” Molecular Therapy Oncology, 2024; 32. https://doi.org/10.1016/j.omton.2024.200760 | H-2Kb/TVYGFCLL |
Dengue Virus (DENV) | |
| Rivino L, et al. (2015). ““Virus-specific T lymphocytes home to the skin during natural dengue infection.” Sci Transl Med. 7(278):278ra35. https://doi.org/10.1126/scitranslmed.aaa0526 | A*11:01/GTSGSPIIDK |
Epstein-Barr Virus (EBV) | |
| Kirchmeier D., et al. (2024). Epstein-Barr virus infection induces tissue-resident memory T cells in mucosal lymphoid tissues. JCI Insight. 2024 Oct 22;9(20):e173489. doi: 10.1172/jci.insight.https://doi.org/10.1172/jci.insight.173489 | A*02:01/CLGGLLTMV |
| Kirchmeier D., et al. (2024). Epstein-Barr virus infection induces tissue-resident memory T cells in mucosal lymphoid tissues. JCI Insight. 2024 Oct 22;9(20):e173489. doi: 10.1172/jci.insight.https://doi.org/10.1172/jci.insight.173489 | A*02:01/GLCTLVAML |
| Fan J., et al. (2024). “IL-15-induced CD38+HLA-DR+CD8+ T cells correlate with liver injury via NKG2D in chronic hepatitis B cirrhosis.” Clin Transl Immunology. 13(10):e70007. doi: 10.1002/cti2.70007. https://doi.org/10.1002/cti2.70007 | A*02:01/GLCTLVAML |
| Serafini B. (2024). “EBV infected cells in the multiple sclerosis brain express PD-L1: How the virus and its niche may escape immune surveillance.” 10.1016/j.jneuroim.2024.578314. https://doi.org/10.1016/j.jneuroim.2024.578314 | B*08:01/FLRGRAYGL |
| Serafini B., et al. (2024). “EBV infected cells in the multiple sclerosis brain express PD-L1: How the virus and its niche may escape immune surveillance.” 10.1016/j.jneuroim.2024.578314. https://doi.org/10.1016/j.jneuroim.2024.578314 | B*08:01/RAKFKQLL |
| Serafini B,. et al. (2019). Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism. J Virol 93:10.1128/jvi.00980-19. https://doi.org/10.1128/jvi.00980-19 | B*08:01/FLRGRAYGL |
| Serafini B,. et al. (2019). Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism. J Virol 93:10.1128/jvi.00980-19. https://doi.org/10.1128/jvi.00980-19 | B*08:01/RAKFKQLL |
Hepatitis B (HBV) | |
| Peña-Asensio J., et al. (2024) “HBsAg level defines different clinical phenotypes of HBeAg(−) chronic HBV infection related to HBV polymerase-specific CD8+ cell response quality.” Front. Immunol. 15:1352929. https://doi.org/10.3389/fimmu.2024.1352929 | A*02:01/FLLTRILTI |
| Peña-Asensio J., et al. (2024) “HBsAg level defines different clinical phenotypes of HBeAg(−) chronic HBV infection related to HBV polymerase-specific CD8+ cell response quality.” Front. Immunol. 15:1352929. https://doi.org/10.3389/fimmu.2024.1352929 | A*02:01/FLPSDFFPSV |
| Fan J., et al. (2024). “IL-15-induced CD38+HLA-DR+CD8+ T cells correlate with liver injury via NKG2D in chronic hepatitis B cirrhosis.” Clin Transl Immunology. 13(10):e70007. doi: 10.1002/cti2.70007. https://doi.org/10.1002/cti2.70007 | A*02:01/FLPSDFFPSV |
| Peña-Asensio J, et al. (2023). “IL-15 boosts activated HBV core-specific CD8+ progenitor cells via metabolic rebalancing in persistent HBV infection.“iScience, 2023; 27. https://doi.org/10.1016/j.isci.2023.108666 | A*02:01/FLPSDFFPSV |
| Peña-Asensio J., et al. (2024) “HBsAg level defines different clinical phenotypes of HBeAg(−) chronic HBV infection related to HBV polymerase-specific CD8+ cell response quality.” Front. Immunol. 15:1352929. https://doi.org/10.3389/fimmu.2024.1352929 | A*02:01/GLSRYVARL |
| Peña-Asensio J, et al. (2023). “IL-15 boosts activated HBV core-specific CD8+ progenitor cells via metabolic rebalancing in persistent HBV infection.“iScience, 2023; 27. https://doi.org/10.1016/j.isci.2023.108666 | A*02:01/GLSRYVARL |
| Rexhouse C., et al. (2025). High antigen burden drives CD8+ T cell dysfunction in a mouse model of chronic hepatitis B virus infection. J Virol. 2025 Jul 22;99(7):e0071125. https://doi.org/10.1128/jvi.00711-25 | H-2Kb/VWLSVIWM |
Human/Simian Immunodeficiency Virus (HIV/SIV) | |
| A. Varin, et al. (2026). “A Subset of Pro-inflammatory CXCL10+ LILRB2+ Macrophages Derives From Recipient Monocytes and Drives Renal Allograft Rejection.” Advanced Science13, no. 10 (2026): e21294. https://doi.org/10.1002/advs.202521294 | A*02:01/SLYNTVATL |
| A. Varin, et al. (2026). “A Subset of Pro-inflammatory CXCL10+ LILRB2+ Macrophages Derives From Recipient Monocytes and Drives Renal Allograft Rejection.” Advanced Science13, no. 10 (2026): e21294. https://doi.org/10.1002/advs.202521294 | B*27:05/KRWIILGLNK |
| S. Jennifer, et al. (2024). “Immunotoxin-mediated depletion of Gag-specific CD8+ T cells undermines natural control of SIV.” JCI Insight. 2024;9(14):e174168. https://doi.org/10.1172/jci.insight.174168 | Mamu-A*01 CTPYDINQM |
Human T-lymphotropic Virus (HTLV) | |
| Tanaka, M., et al. (2024). “HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load.” Int. J. Mol. Sci. 2024, 25, 6858. https://doi.org/10.3390/ijms25136858 | A*24:02/SFHSLHLLF |
Influenza | |
| Delacher M., et al. (2024). “The effector program of human CD8 T cells supports tissue remodeling.” J Exp Med. 2024 Feb 5;221(2):e20230488. doi: 10.1084/jem.20230488. Epub 2024 Jan 16. https://doi.org/10.1084/jem.20230488 | A*02:01/GILGFVFTL |
| Lin Y, et al. (2026). “Regulatory T cell-derived TGF-β signaling governs the differentiation and maintenance of tumor-infiltrating bystander CD8+ T cells.“Cell Reports, 2026; 45. https://doi.org/10.1016/j.celrep.2026.117189 | A*11:01/SIIPSGPLK |
| Valentin C, et al. (2025). “Maternal probiotic exposure enhances CD8 T cell protective neonatal immunity and modulates offspring metabolome to control influenza virus infection.” Gut Microbes, 17(1). https://doi.org/10.1080/19490976.2024.2442526 | H-2Db/SCLENFRAYV |
| Sallah H, et al. (2025) “Manipulating the delivery and immunogenicity of DNA vaccines through the addition of CB[8] to cationic polymers.“Molecular Therapy Nucleic Acids, 2025; 36. https://doi.org/10.1016/j.omtn.2025.102585 | H-2Kd/IYSTVASSL |
| Bissett, C., et al. (2024). “Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine.” npj Vaccines 9, 118 (2024). https://doi.org/10.1038/s41541-024-00912-1 | H-2Kd/TYQRTRALV |
| Vieira Antão A, et al. (2024) “Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus.“Front. Immunol. 15:1376395. https://doi.org/10.1038/s41541-024-00912-1 | H-2Kd/TYQRTRALV |
Model Antigen | |
| Lim, K.H.J., et al. (2026) “Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunity.” Nat Immunol 27, 72–81 (2026). https://doi.org/10.1038/s41590-025-02354-w | H-2Kb/SIINFEKL |
| Sanlorenzo, M., et al. (2025) “Systemic IFN-I combined with topical TLR7/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells.” Nat Cancer 6, 175–193 (2025). https://doi.org/10.1038/s43018-024-00889-9 | H-2Kb/SIINFEKL |
| Lei, M.M.L., et al. (2025) “Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma.” Nat Commun 16, 9913 (2025). https://doi.org/10.1038/s41467-025-64860-7 | H-2Kb/SIINFEKL |
| Gaskarth DA, et al. (2025) “The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity.” Front. Med. 12:1577906. https://doi.org/10.3389/fmed.2025.1577906 | H-2Kb/SIINFEKL |
| Kotkowska Z, et al. (2025). “Inflammatory Cutaneous Reactions with Systemic CD8+ T-Cell Responses upon Photochemical Internalization of Antigens in Mice.“Journal of Investigative Dermatology, 2025; 145, 3115-3125.e8. https://doi.org/10.1016/j.jid.2025.04.020 | H-2Kb/SIINFEKL |
| Russo S, et al. (2024). “Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy.“ Molecular Therapy Oncology, 2024; 32. https://doi.org/10.1016/j.omton.2024.200766 | H-2Kb/SIINFEKL |
| Joshi S, et al. (2024). “Tim4 enables large peritoneal macrophages to cross-present tumor antigens at early stages of tumorigenesis.” Cell Reports, 2024; 43. https://doi.org/10.1016/j.celrep.2024.114096 | H-2Kb/SIINFEKL |
| Troise F, et al. (2024) “Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors.“Molecular Therapy Oncology, 2024; 32. https://doi.org/10.1016/j.omton.2024.200760 | H-2Kb/SIINFEKL |
| Lin F, et al. (2024) “Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment.” Cell, 2024; 187, 7470-7491.e32. https://doi.org/10.1016/j.cell.2024.10.016 | H-2Kb/SIINFEKL |
| D. Koumantou, et al. 2024). “Specific Requirement of the p84/p110γ Complex of PI3Kγ for Antibody-Activated, Inducible Cross-Presentation in Murine Type 2 DCs.” Adv. Sci.2024, 11, 2401179. H-2Kb/SIINFEKL | |
| Jones TA, et al. (2026) “Targeting the novel immune checkpoint KLRG1 is markedly therapeutic against cancer through multiple lymphocyte subsets.” Journal for ImmunoTherapy of Cancer 2026;14:e013869. https://doi.org/10.1136/jitc-2025-013869 | H-2Kb/SIYRYYGL |
| Li S, et al. (2025). “Tumor Cell–Intrinsic Decr2 Regulates Ferroptosis and Immunotherapy Efficacy.” Cancer Immunol Res 1 August 2025; 13 (8): 1284–1302. https://doi.org/10.1158/2326-6066.CIR-24-0519 | H-2Kb/SIYRYYGL |
| Ziblat A, et al. (2024). “Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy.” Cell Reports, 2024; 43. https://doi.org/10.1016/j.celrep.2024.114141 | H-2Kb/SIYRYYGL |
| Anne R. Diers, et al. (2025). “Dynamic tracking of tumor microenvironment modulation using Kaede photoconvertible transgenic mice unveils new biological properties of viral immunotherapy.” Cancer Research Communications 2025. https://doi.org/10.1158/2767-9764.CRC-24-0434 | H-2Kb/KSPWFTTL |
Rabies Virus (RABV) | |
| van Zyl DG, et al. (2024) “Poly(2-methyl-2-oxazoline) as a polyethylene glycol alternative for lipid nanoparticle formulation. “Front. Drug Deliv. 4:1383038. https://doi.org/10.3389/fddev.2024.1383038 | H-2Ld/LPNWGKYVL |
Respiratory Syncytial Virus (RSV) | |
| Vieira Antão A, et al. (2024) “Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus.” Front. Immunol. 15:1376395. https://doi.org/10.1038/s41541-024-00912-1 | H-2Kd/KYKNAVTEL |
| Bissett, C., et al. (2024). “Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine.” npj Vaccines 9, 118 (2024). https://doi.org/10.1038/s41541-024-00912-1 | H2Kd/KYKNAVTEL |
| Fuchs, J., et al. (2024). “Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus.” npj Vaccines 9, 205 (2024). https://doi.org/10.1038/s41541-024-01001-z | H2Kd/KYKNAVTEL |
| Wang Z, et al. (2024). “IL-1α is required for T cell-driven weight loss after respiratory viral infection.“ Mucosal Immunology, 2024; 17, 272-287. https://doi.org/10.1016/j.mucimm.2024.02.005 | H-2Kd/SYIGSINNI |
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) | |
| Peng, Y., et al. (2020). “Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.” Nat Immunol 21, 1336–1345 (2020). https://doi.org/10.1038/s41590-020-0782-6 | A*01:01/FTSDYYQLY |
| Rha M, et al. (2020) “PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19.” Immunity, 2020; 54, 44-52.e3. https://doi.org/10.1016/j.immuni.2020.12.002 | A*02:01/ALNTLVKQL |
| Jung S, et al. (2022) “The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses” Cell Reports, 2022; 40. https://doi.org/10.1016/j.celrep.2022.111138 | A*02:01/FIAGLIAIV |
| Rha M, et al. (2020) “PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19.” Immunity, 2020; 54, 44-52.e3. https://doi.org/10.1016/j.immuni.2020.12.002 | A*02:01/FIAGLIAIV |
| Nguema L, et al. (2024). “Subunit protein CD40.SARS.CoV2 vaccine induces SARS-CoV-2-specific stem cell-like memory CD8+ T cells.” eBioMedicine, 2024; 111. https://doi.org/10.1016/j.ebiom.2024.105479 | A*02:01/KIADYNYKL |
| Jung S, et al. (2022) “The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses” Cell Reports, 2022; 40. https://doi.org/10.1016/j.celrep.2022.111138 | A*02:01/LITGRLQSL |
| Rha M, et al. (2020) “PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19.” Immunity, 2020; 54, 44-52.e3. https://doi.org/10.1016/j.immuni.2020.12.002 | A*02:01/LITGRLQSL |
| Jung S, et al. (2022) “The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses” Cell Reports, 2022; 40. https://doi.org/10.1016/j.celrep.2022.111138 | A*02:01/RLQSLQTYV |
| Rha M, et al. (2020) “PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19.” Immunity, 2020; 54, 44-52.e3. https://doi.org/10.1016/j.immuni.2020.12.002 | A*02:01/RLQSLQTYV |
| Nguema L, et al. (2024). “Subunit protein CD40.SARS.CoV2 vaccine induces SARS-CoV-2-specific stem cell-like memory CD8+ T cells.” eBioMedicine, 2024; 111. https://doi.org/10.1016/j.ebiom.2024.105479 | A*02:01/YLQPRTFLL |
| Jung S, et al. (2022) “The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses” Cell Reports, 2022; 40. https://doi.org/10.1016/j.celrep.2022.111138 | A*02:01/YLQPRTFLL |
| Jung, J.H., et al. (2021). “SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.” Nat Commun 12, 4043 (2021). https://doi.org/10.1038/s41467-021-24377-1 | A*02:01/YLQPRTFLL |
| Rha M, et al. (2020) “PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19.” Immunity, 2020; 54, 44-52.e3. https://doi.org/10.1016/j.immuni.2020.12.002 | A*02:01/YLQPRTFLL |
| Peng, Y., et al. (2020). “Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.” Nat Immunol 21, 1336–1345 (2020). https://doi.org/10.1038/s41590-020-0782-6 | A*03:01/KTFPPTEPK |
| Peng, Y., et al. (2020). “Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.” Nat Immunol 21, 1336–1345 (2020). https://doi.org/10.1038/s41590-020-0782-6 | A*11:01/KTFPPTEPK |
| Peng, Y., et al. (2020). “Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.” Nat Immunol 21, 1336–1345 (2020). https://doi.org/10.1038/s41590-020-0782-6 | B*07:02/SPRWYFYYL |
| Peng, Y., et al. (2022) “An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease.” Nat Immunol 23, 50–61 (2022). https://doi.org/10.1038/s41590-021-01084-z | B*27:05/QRNAPRITF |
| Peng, Y., et al. (2020). “Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.” Nat Immunol 21, 1336–1345 (2020). https://doi.org/10.1038/s41590-020-0782-6 | B*27:05/QRNAPRITF |
| Zhu, A., et al. (2025) “Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs.” Nat Immunol 26, 459–472 (2025). https://doi.org/10.1038/s41590-024-02072-9 | B*40:01/MEVTPSGTWL |
| Peng, Y., et al. (2020). “Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.” Nat Immunol 21, 1336–1345 (2020). https://doi.org/10.1038/s41590-020-0782-6 | B*40:01/MEVTPSGTWL |